Trademarks

NALMEFENE HCL

Serial number
99710822
Registration number
Not registered
Filed
2026-03-18
Registered
Not registered
Status
Pending application (USPTO status code 681, 2026-10-15; as of the dataset)
Classes
005
Elsewhere
USPTO TSDR record (current status) ↗
Source
TRTDXFAP, file of 2026-10-16

Goods and services

Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists

Owners

OwnerRoleEntityPlaceAlso on furp.orgSource
Purdue Pharma L.P.Original applicantEntity Code 13Stamford, CTPURDUE PHARMA L.P. State business registration EXACT high confidence: identical full name and stateTRTDXFAP, file of 2026-10-16
KNOA PHARMA LLCNew applicant before publicationLimited Liability CompanySTAMFORD, CTTRTDXFAP, file of 2026-10-16

Assignment history

RecordedWhatFromToReel/frameSource
2026-05-18Assignment
Assigns the entire interest
PURDUE PHARMA L.P.KNOA PHARMA LLC STAMFORD, CT9274/281TRTDXFAG, file of 2026-08-14

USPTO bulk data: the Trademark Case Files Dataset (TRCFECO2; the latest release, March 2024, runs through 2023) for marks, owners, classes and goods and services; the Trademark Assignment Dataset (TRASECO) for assignments. Marks filed in the last 20 years, plus older marks still registered. Status here is read from the dataset’s dates and status code; TSDR has the current status. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.